ABSTRACT
Coronavirus disease has myriad manifestations and can present with predominantly extrapulmonary manifestations. We describe a 50-year-old man, a person living with HIV (PLHA), a non-Hodgkin lymphoma survivor, who presented with isolated severe thrombocytopenia. He was found to have immune-mediated thrombocytopenia, and showed excellent response to intravenous immunoglobulins.
ABSTRACT
Introduction: Men have been suffering from urinary stones since antiquity. Symptomatic ureteric stone is a very common emergency condition faced by general surgeons and urologists. There are many medical and interventional treatments for lower ureteric stones. Removal of stone with ureteroscopy is very effective but this is very costly also. Anesthetist is required; stent is placed in ureter which has to be removed afterward. Stones of size <4 mm will pass hopefully spontaneously. Stones more than 10 mm size will require surgery in general. The expulsion of stones of size 4–10 mm can be tried with the help of pharmacological agents. Materials and Methods: This prospective observational study was conducted in the Surgery Department at SGT Medical College located in South Haryana. A total of 150 patients of distal ureteric stones of sizes 4–10 mm were taken in this study, divided into two groups of 75 patients each. Group I patients were given tamsulosin 0.4 mg and deflazacort 30 mg once in a day and Group II patients were given tamsulosin 0.4 mg once in a day. Treatment was for 10 days. Results: In Group I, the stones were expelled in 24 (32%) patients. While in Group II, 11 (14.6%) patients passed stones. This is statistically significant with P = 0.023. The median time for stone expulsion was 192 h in Group I and 312 h in Group II with again a significant P = 0.039. Conclusion: We conclude that Group I (tamsulosin + deflazacort) showed a statistically significant advantage in stone expulsion rate than Group II (tamsulosin alone). Group I also showed a statistically significant advantage in stone expulsion time.